FACIT-Fatigue scale scores by BILAG groups.

Mean (SD)Effect Sizep
BILAG Cardiorespiratory Group
  BaselineC/D/E (n = 195)19.2 (11.4)C/D/E vs B: −0.070.410
B (n = 45)20.0 (11.7)B vs A: 0.39
A (n = 14)15.3 (12.6)
  Week 12C/D/E (n = 213)25.0 (13.1)C/D/E vs B: 0.02NC
B (n = 16)24.8 (12.0)B vs A: NC
A (n = 1)2.0 (NA)
BILAG Hematologic Group
  BaselineC/D/E (n = 194)18.5 (11.2)C/D/E vs B: −0.26NC
B (n = 56)21.4 (12.8)B vs A: NC
A (n = 4)17.5 (9.3)
  Week 12C/D/E (n = 200)24.6 (13.0)−0.160.403
B (n = 30)26.7 (13.4)
BILAG Mucocutaneous Group
  BaselineC/D/E (n = 71)16.9 (9.7)C/D/E vs B: −0.260.144
B (n = 144)19.8 (12.3)B vs A: −0.06
A (n = 39)20.5 (11.3)
  Week 12C/D/E (n = 158)25.5 (12.9)C/D/E vs B: 0.140.452
B (n = 57)23.7 (13.6)B vs A: 0.12
A (n = 15)22.1 (12.4)
BILAG Neurological Group
  BaselineC/D/E (n = 222)19.7 (11.7)C/D/E vs B: 0.52NC
B (n = 26)13.8 (9.6)B vs A: NC
A (n = 6)19.5 (9.3)
  Week 12C/D/E (n = 215)25.4 (13.0)C/D/E vs B: 0.80NC
B (n = 13)15.2 (11.5)B vs A: NC
A (n = 2)23.5 (7.8)
BILAG Renal Group
  BaselineC/D/E (n = 251)19.2 (11.6)NCNC
B (n = 3)15.3 (10.5)C/D/E vs B: NCNC
  Week 12C/D/E (n = 218)24.7 (13.1)B vs A: NC
B (n = 9)26.6 (10.9)
A (n = 3)33.6 (17.0)
BILAG Vasculitis Group
  BaselineC/D/E (n = 216)18.5 (11.0)C/D/E vs B: −0.55NC
B (n = 30)24.8 (14.4)B vs A: NC
A (n = 8)13.6 (6.6)
  Week 12C/D/E (n = 216)24.8 (12.8)C/D/E vs B: −0.13NC
B (n = 11)26.5 (16.4)B vs A: NC
A (n = 3)23.0 (18.2)
  • FACIT: Functional Assessment of Chronic Illness Therapy; BILAG: British Isles Lupus Assessment Group; NC: not calculated (when group sample size < 10).